Sangamo BioSciences Announces Presentation At The 2015 Morgan Stanley Global Healthcare Conference

Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and an overview of the company's business strategy at 9:55am ET on Friday, September 18, 2015, at the 2015 Morgan Stanley Global Healthcare Conference. The conference is being held in New York, NY